EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy

Benjamin Madden, Raman Deep Singh, Mark Haas, Lilian M P Palma, Alok Sharma, Maria J Vargas, LouAnn Gross, Vivian Negron, Torell Nate, M Cristine Charlesworth, Jason D Theis, Samih H Nasr und 3 weitere

Kidney International · 2024-05 · 105 (5) · 1077-1087

DOI: 10.1016/j.kint.2024.02.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2024-05. Verfasst von Benjamin Madden und 14 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Proteomics Core, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranoproliferative, Glomerulonephritis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Catholic Medical Center, National Cancer Institute, Fibrolamellar Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C3 glomerulopathy (C3G) is a rare disease resulting from dysregulation of the alternative pathway of complement. C3G includes C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), both of which are characterized by bright glomerular C3 staining on immunofluorescence studies. However, on electron microscopy (EM), DDD is characterized by dense osmiophilic mesangial and intramembranous deposits along the glomerular basement membranes (GBM), while the deposits of C3GN are not dense. Why the deposits appear dense in DDD and not in C3GN is not known. We performed laser microdissection (LCM) of glomeruli followed by mass spectrometry (MS) in 12 cases each of DDD, C3GN, and pretransplant kidney control biopsies. LCM/MS showed marked accumulation of complement proteins C3, C5, C6, C7, C8, C9 and complement regulating proteins CFHR5, CFHR1, and CFH in C3GN and DDD compared to controls. C3, CFH and CFHR proteins were comparable in C3GN and DDD. Yet, there were significant differences. First, there was a six-to-nine-fold increase of C5-9 in DDD compared to C3GN. Secondly, an unexpected finding was a nine-fold increase in apolipoprotein E (ApoE) in DDD compared to C3GN. Most importantly, immunohistochemical and confocal staining for ApoE mirrored the dense deposit staining in the GBM in DDD but not in C3GN or control cases. Validation studies using 31 C3G cases confirmed the diagnosis of C3GN and DDD in 80.6 % based on ApoE staining. Overall, there is a higher burden of terminal complement pathway proteins in DDD compared to C3GN. Thus, our study shows that dense deposits in DDD are enriched with ApoE compared to C3GN and control cases. Hence, ApoE staining may be used as an adjunct to EM for the diagnosis of DDD and might be valuable when EM is not available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranoproliferativeGlomerulonephritisHumansKidney GlomerulusApolipoproteins EApolipoproteins

Stichwörter der Autor:innen

C3 glomerulonephritisapolipoprotein Ecomplementdense deposit disease

Substanzen

Apolipoproteins EApolipoproteins

Autor:innen und Institutionen

  • Mayo Clinic Proteomics Core, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Pediatric Nephrology, State University of Campinas (UNICAMP), Campinas, Brazil.
  • Department of Renal Pathology & Electron Microscopy, Dr Lal Path Labs, New Delhi, India.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Förderung

  • Catholic Medical Center
  • National Cancer Institute
  • Fibrolamellar Cancer Foundation
  • Mayo Clinic
  • Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine

Zitieren

APA

Madden, B., Singh, R. D., Haas, M., Palma, L. M. P., Sharma, A., Vargas, M. J., Gross, L., Negron, V., Nate, T., Charlesworth, M. C., Theis, J. D., Nasr, S. H., Nath, K. A., Fervenza, F. C., & Sethi, S. (2024). Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy. Kidney International, 105(5), 1077-1087. https://doi.org/10.1016/j.kint.2024.02.013

Vancouver

Madden B, Singh RD, Haas M, Palma LMP, Sharma A, Vargas MJ, et al. Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy. Kidney International. 2024;105(5):1077-1087. doi:10.1016/j.kint.2024.02.013

BibTeX
@article{Madden2024,
  author = {Madden, Benjamin and Singh, Raman Deep and Haas, Mark and Palma, Lilian M P and Sharma, Alok and Vargas, Maria J and Gross, LouAnn and Negron, Vivian and Nate, Torell and Charlesworth, M Cristine and Theis, Jason D and Nasr, Samih H and Nath, Karl A and Fervenza, Fernando C and Sethi, Sanjeev},
  title = {Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy},
  journal = {Kidney International},
  year = {2024},
  volume = {105},
  number = {5},
  pages = {1077--1087},
  doi = {10.1016/j.kint.2024.02.013}
}
Kostenlos starten →